These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10586395)

  • 21. Lansoprazole: an alternative method of administration of a capsule dosage formulation.
    Chun AH; Eason CJ; Shi HH; Cavanaugh JH
    Clin Ther; 1995; 17(3):441-7. PubMed ID: 7585848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole.
    Freston JW; Pilmer BL; Chiu YL; Wang Q; Stolle JC; Griffin JS; Lee CQ
    Aliment Pharmacol Ther; 2004 May; 19(10):1111-22. PubMed ID: 15142201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    Andersson T; Holmberg J; Röhss K; Walan A
    Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.
    Itagaki F; Homma M; Yuzawa K; Nishimura M; Naito S; Ueda N; Ohkohchi N; Kohda Y
    J Pharm Pharmacol; 2004 Aug; 56(8):1055-9. PubMed ID: 15285851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of lansoprazole.
    Landes BD; Petite JP; Flouvat B
    Clin Pharmacokinet; 1995 Jun; 28(6):458-70. PubMed ID: 7656504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion.
    Metz DC; Devlin JW; Vakily M; Atkinson S; Lloyd E
    Pharmacotherapy; 2008 Mar; 28(3):301-7. PubMed ID: 18294109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF; Fraser R; Armstrong D; Blum AL
    Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lansoprazole pharmacokinetics differ in patients with oesophagitis compared to healthy volunteers.
    Barclay ML; Begg EJ; Robson RA; Peters WA; Ketelbey JW
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1215-9. PubMed ID: 10468704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity.
    Bachmann KA; Sullivan TJ; Jauregui L; Reese JH; Miller K; Levine L
    Br J Clin Pharmacol; 1993 Oct; 36(4):380-2. PubMed ID: 12959321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
    Mainz D; Borner K; Koeppe P; Kotwas J; Lode H
    J Antimicrob Chemother; 2002 Nov; 50(5):699-706. PubMed ID: 12407126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole.
    Thoring M; Hedenström H; Eriksson LS
    Scand J Gastroenterol; 1999 Apr; 34(4):341-5. PubMed ID: 10365892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S
    Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation.
    Chun AH; Erdman K; Chiu YL; Pilmer BL; Achari R; Cavanaugh JH
    Clin Ther; 2002 Aug; 24(8):1322-31. PubMed ID: 12240782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules.
    Amer F; Karol MD; Pan WJ; Griffin JS; Lukasik NL; Locke CS; Chiu YL
    Clin Ther; 2004 Dec; 26(12):2076-83. PubMed ID: 15823771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interaction between lansoprazole and theophylline.
    Granneman GR; Karol MD; Locke CS; Cavanaugh JH
    Ther Drug Monit; 1995 Oct; 17(5):460-4. PubMed ID: 8585108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
    Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
    J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
    Purkins L; Wood N; Ghahramani P; Love ER; Eve MD; Fielding A
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):37-44. PubMed ID: 14616412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube.
    Chun AH; Shi HH; Achari R; Dennis S; Cavanaugh JH
    Clin Ther; 1996; 18(5):833-42. PubMed ID: 8930427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease.
    Gremse D; Winter H; Tolia V; Gunasekaran T; Pan WJ; Karol M; Chiu YL; Pilmer B; Book L
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S319-26. PubMed ID: 12607792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.